Note: Ingredients listed on restricted chemical lists
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
EC/CAS
69-65-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Version
02/13/2024
Revision date
2024-02-13
Product name
Bivalirudin for Injection
Product name
Bivalirudin for Injection
Identification on the label/Trade name
Bivalirudin for Injection | Manufacturer Fresenius Kabi USA LLC
Manufacturer Name
Fresenius Kabi USA, LLC
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
Section 2
SECTION 2: Hazards identification
Emergency Overview This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation Ingestion Eye contact Skin Absorption. Injection.
Potential health effects
Eye Contact with eyes may cause irritation. Skin May cause skin irritation. Inhalation May cause irritation of respiratory tract. Ingestion May cause irritation. Signs/Symptoms Potential adverse reactions from prescribed doses and overdoses are described in the package insert. Adverse reactions from therapeutic doses include: headache, nausea, backpain, hypertension/hypotension and fatigue. There is no experience to date with deliberate overdosage. Occupational exposure has not been fully investigated.
